Geoffrey R. Erickson
Fondatore presso Immunis.AI, Inc.
Profilo
Dr. Geoffrey R.
Erickson is a Director-Business Development at Office of Technology Development.
Prior to joining OTD in 2009, he was CEO of Humacyte, Inc., a company created from technology out of Duke University and MIT.
Prior to his role at Humacyte, Dr. Erickson was a venture capitalist with Pappas Ventures, a firm focused on investments in the life science industry which he joined in 2001.
In addition, he worked with Pappas Ventures as a co-founder of CoLucid Pharmaceuticals.
Dr. Erickson received a BSE in engineering from Duke University, an MSE in engineering from Tulane University, and a PhD in biomedical engineering from Duke University.
Posizioni attive di Geoffrey R. Erickson
| Società | Posizione | Inizio |
|---|---|---|
Immunis.AI, Inc.
 Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis. | Fondatore | - |
Precedenti posizioni note di Geoffrey R. Erickson
| Società | Posizione | Fine |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Presidente | 31/12/2008 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Analista di Private Equity | 31/12/2007 |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Formazione di Geoffrey R. Erickson
| Duke University | Doctorate Degree |
| Tulane University (Louisiana) | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Immunis.AI, Inc.
Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis. | Technology Services |
- Borsa valori
- Insiders
- Geoffrey R. Erickson
